Eir Partners Majority Recapitalizes PharmaForceIQ

September 10, 2024

Eir Partners completed a majority recapitalization of PharmaForceIQ (PFIQ), an AI-driven omnichannel orchestration and measurement platform for pharmaceutical and life science companies. The investment will fund product development, key hires and continued accumulation of data assets to scale PFIQ's HCP and DTC omnichannel offerings.

Buyers
Eir Partners
Targets
PharmaForceIQ
Industry
Cloud & SaaS
Location
Massachusetts and Florida, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.